Rapid Immunoassays Rise in Emergency Diagnostics Use
Rapid immunoassays have emerged as a valuable tool for providing quick information that can be crucial in life-threatening situations.
Rapid immunoassays have emerged as a valuable tool for providing quick information that can be crucial in life-threatening situations.
A new study demonstrated how rapid antigen test can be used to triage healthcare workers for returning to work during staffing shortages.
Researchers built an RT-PCR platform that gives results in 23 minutes that match the longer laboratory-based tests.
The FDA has granted Pathogenomix with a Breakthrough Device Designation for its Patho-Seq assay due to its methodologies of pathogenic bacteria diagnosis.
Read MoreGS Labs rapid antigen tests also had a 26% positivity rate, up from 22% the previous week and was only 8% during Thanksgiving week.
Read MoreA study that screened asymptomatic workers for SARS-CoV-2 via rapid tests showed the rate of false-positive results among the total screens was very low.Â
Read MoreMeridian Bioscience says its Curian Campy assay—an immunoassay for the detection of a Campylobacter-specific antigen—received FDA clearance. Â
Read MoreA portable and rapid prostate cancer screening kit could provide early warning to populations with higher incidence of prostate cancer.
Read MoreThe FDA alerted that false reactivity Rapid Plasma Reagin test results in a Bio-Rad RPR kit can occur for some who received a COVID-19 vaccine.
Read MoreLumiraDx’s SARS-CoV-2 assay will now offer a self-collected COVID-19 nasal specimen collection kit through a new partnership with Audere.
Read MoreA new study found COVID-19 rapid antigen detection tests proved more effective than expected when compared to the polymerase chain reaction (PCR) assay.
Read MoreThe LumiraDx SARS-CoV-2 RNA STAR Complete has been authorized by FDA for emergency use under an EUA for use by authorized laboratories.Â
Read MoreThe Maverick line of qPCR instruments from Anitoa Systems has received U.S. FDA registration and device listing as class II 510(k) exempt medical devices.
Read MoreWhile welcoming a renewed emphasis on testing, some healthcare leaders warn that America’s path forward requires balancing testing speed with accuracy.
Read MoreRockefeller University’s “DRUL” saliva test performs as well as, if not better, than FDA-authorized nasal and oral swab tests.
Read MoreVisby Medical has received a 510(k) clearance to market its fast, single-use PCR diagnostic test for the detection of STIs.
Read MoreBD has announced the U.S. FDA has issued an Emergency Use Authorization (EUA) for the BD Veritor At-Home COVID-19 Test.
Read MoreNew England Biolabs (NEB) has released its newest loop-mediated isothermal amplification (LAMP) products, allowing for rapid, high throughput tests.
Read More